As the H1N1 Flu virus (swine flu) is now officially declared a pandemic we should be mindful of the possibility, for those of us who are included in certain medical categories, of developing life threatening pneumonia infection should we contract this virus at some point in the coming year.
I have put the full guidance and further links to information under Newswire. There is a list of the groups of people that are considered to be more at risk, which includes those with leukaemia and those that have had bone marrow transplants and/or splenectomy, amongst others.
It might be wise for those of us in the following at risk categories to check with our doctor to see if and/or when a Pneumococcal polysaccharide vaccine (PPSV23) was given and if it was over 5 years ago, ask to be vaccinated again.
Sandy
Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak
June 9, 2009
Table. U.S. ACIP recommendations for use of pneumococcal polysaccacharide vaccine.
Pneumococcal polysaccharide vaccine (PPSV23)
Universal vaccination
All adults 65 years of age and older
Medical Indications
Persons 2 through 64 years of age who have one or more of the following long-term health problems:
* chronic cardiovascular disease (congestive heart failure and cardiomyopathies)
* chronic pulmonary disease including chronic obstructive pulmonary disease and emphysema
* diabetes mellitus
* alcoholism
* chronic liver disease, including cirrhosis
* cerebrospinal fluid leaks
* functional or anatomic asplenia including sickle cell disease and splenectomy
* immunocompromising conditions including HIV infection, leukemia, lymphoma, Hodgkin’s disease, multiple myeloma, generalized malignancy, chronic renal failure, nephrotic syndrome; those receiving immunosuppressive chemotherapy (including corticosteroids); and those who have received an organ or bone marrow transplant